COVID-19 and restrictive lung disease: A deadly combo to trip off the fine balance

Abstract

Coronavirus Disease (COVID-19) pandemic has so far led to innumerable deaths worldwide. The risk factors so far that have been most studied as poor prognostic factors are old age, individuals with multiple comorbidities and immunocompromised patients. Amongst the chronic lung diseases, most patients with COVID-19 reported so far had asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung disease. Herein, we discuss the significance of restrictive lung disease during the COVID-19 pandemic as a potential risk factor via an example of a patient with kyphoscoliosis who succumbed to death due to COVID-19 pneumonia.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2020-06-29
Info
Issue
Section
COVID-19 - Collection of articles on the Coronavirus outbreak
Keywords:
COVID-19, virus, lung, kyphoscoliosis
Statistics
  • Abstract views: 174

  • PDF: 120
How to Cite
Sahu, K. K., Mishra, A. K., Martin, K., & Chastain, I. (2020). COVID-19 and restrictive lung disease: A deadly combo to trip off the fine balance. Monaldi Archives for Chest Disease, 90(2). https://doi.org/10.4081/monaldi.2020.1346

Most read articles by the same author(s)